Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

NCT04795622 NA COMPLETED Results posted

1. Demonstrate superiority of treatment with the Ulthera DeepSEE System compared to untreated control for the improvement of skin laxity of the lower face and submental area. 2. Demonstrate the safety of treatment with the Ulthera DeepSEE System for the improvement of skin laxity of the lower face and submental area.

Details

Lead sponsor	Merz North America, Inc.
Phase	NA
Status	COMPLETED
Enrolment	201
Start date	Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Improvement in Skin Laxity of the Lower Face and Submentum

Interventions

• Ultherapy treatment
• Untreated-control / delayed-treatment

Countries

China